This Midwest-based healthcare practice delivers IV ketamine treatments tailored for individuals facing persistent mental health and pain-related conditions. The clinic has conducted more than 15,000 sessions and maintains a base of approximately 600 active clients, earning a trusted position in a region with limited access to innovative therapies.

The vast majority of earnings stem from ketamine infusions targeting conditions such as severe depression, anxiety disorders, PTSD, OCD, and chronic pain syndromes. The clinic also offers IV therapy for short-term issues like migraines and hangovers, along with remote ADHD evaluations and medication support, delivered under a distinct telehealth brand. Client satisfaction is high, with glowing reviews and strong loyalty.

Operations are led by board-certified nurse practitioners who are deeply involved in day-to-day care. They are joined by a small clinical team, including a paramedic and part-time nursing professionals, who handle patient intake, treatment, and follow-up care.

With a typical session priced under $300 and low direct costs, the clinic operates with excellent margins. Significant room for expansion exists through the potential introduction of Spravato (covered by insurance), broadening of ADHD-related services, addition of medical cannabis evaluations, and launching satellite locations in other states.

The current owners are seeking a strategic partner or investor to help scale operations. They are open to remaining involved after the sale to assist with a smooth transition and support long-term growth initiatives.